Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04469764
Title Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors Jonsson Comprehensive Cancer Center
Indications

peritoneum cancer

fallopian tube cancer

ovary epithelial cancer

endometrial carcinoma

Therapies

Abemaciclib + Anastrozole

Abemaciclib + Letrozole

Abemaciclib

Age Groups: child | senior | adult
Covered Countries USA

Additional content available in CKB BOOST